STOCK TITAN

Emerson Elec Co Financials

EMR
FY2025 annual
Revenue $18.0B +3.0% YoY
Net Income $2.3B +16.5% YoY
EPS (Diluted) Not reported for FY2025
Free Cash Flow $2.7B -8.4% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE September

Emerson Elec Co (EMR) reported $18.0B in revenue for fiscal year 2025, up 3.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EMR FY2025

Emerson's margin expansion coexists with weaker cash conversion and a more debt-dependent liquidity posture.

Gross margin reached 52.8% in FY2025, yet free cash flow declined from the prior year; better unit economics did not produce more distributable cash. Operating cash flow of $3.1B exceeded net income of $2.3B, indicating cash-backed earnings even as free cash flow weakened.

Revenue reached $18.0B while SG&A held near $5.1B; cost growth did not absorb the added gross profit. That operating shape helped net margin reach 12.7%, reflecting improved earnings capture rather than mere top-line expansion.

Cash fell to $1.5B while long-term debt rose to $8.3B, increasing reliance on debt funding. A current ratio of 0.9x indicates a short-term coverage gap, with current assets below current liabilities.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 36 / 100
Financial Health Score 36/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Emerson Elec Co's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

Not available for Emerson Elec Co, and counted as zero in the overall score.

Growth
63

Emerson Elec Co's revenue grew a modest 3.0% year-over-year to $18.0B. This slow but positive growth earns a score of 63/100.

Leverage
63

Emerson Elec Co has a moderate D/E ratio of 0.41. This balance of debt and equity financing earns a leverage score of 63/100.

Liquidity
14

Emerson Elec Co's current ratio of 0.88 is below the typical benchmark, resulting in a score of 14/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
74

Emerson Elec Co converts 14.8% of revenue into free cash flow ($2.7B). This strong cash generation earns a score of 74/100.

Returns
0

Not available for Emerson Elec Co, and counted as zero in the overall score.

Piotroski F-Score Strong
7/9

Emerson Elec Co passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.35x

For every $1 of reported earnings, Emerson Elec Co generates $1.35 in operating cash flow ($3.1B OCF vs $2.3B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$18.0B
YoY+3.0%
5Y CAGR+1.4%
10Y CAGR+1.0%

Emerson Elec Co generated $18.0B in revenue in fiscal year 2025. This represents an increase of 3.0% from the prior year.

Net Income
$2.3B
YoY+16.5%
5Y CAGR+3.1%
10Y CAGR-1.7%

Emerson Elec Co reported $2.3B in net income in fiscal year 2025. This represents an increase of 16.5% from the prior year.

EBITDA

Not reported for fiscal year 2025.

EPS (Diluted)

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
$2.7B
YoY-8.4%
5Y CAGR+0.9%
10Y CAGR+3.2%

Emerson Elec Co generated $2.7B in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 8.4% from the prior year.

Cash & Debt
$1.5B
YoY-57.0%
5Y CAGR-14.2%
10Y CAGR-6.6%

Emerson Elec Co held $1.5B in cash against $8.3B in long-term debt as of fiscal year 2025.

Shares Outstanding
562M
YoY-1.5%
5Y CAGR-1.2%
10Y CAGR-1.5%

Emerson Elec Co had 562M shares outstanding in fiscal year 2025. This represents a decrease of 1.5% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
52.8%
YoY+2.0pp
5Y CAGR+11.1pp
10Y CAGR+9.7pp

Emerson Elec Co's gross margin was 52.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.0 percentage points from the prior year.

Net Margin
12.7%
YoY+1.5pp
5Y CAGR+1.0pp
10Y CAGR-4.0pp

Emerson Elec Co's net profit margin was 12.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.5 percentage points from the prior year.

Return on Equity
11.3%
YoY+2.2pp
5Y CAGR-12.1pp
10Y CAGR-22.2pp

Emerson Elec Co's ROE was 11.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.2 percentage points from the prior year.

Operating Margin

Not reported for fiscal year 2025.

Capital Allocation

R&D Spending
$771.0M
YoY-1.3%
5Y CAGR+11.9%
10Y CAGR+8.7%

Emerson Elec Co invested $771.0M in research and development in fiscal year 2025. This represents a decrease of 1.3% from the prior year.

Share Buybacks
$1.2B
YoY+168.3%
5Y CAGR+4.4%
10Y CAGR-7.3%

Emerson Elec Co spent $1.2B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 168.3% from the prior year.

Capital Expenditures
$431.0M
YoY+2.9%
5Y CAGR-4.3%
10Y CAGR-3.1%

Emerson Elec Co invested $431.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 2.9% from the prior year.

EMR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EMR annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$18.6B$18.0B+3.0%$17.5B+15.3%$15.2B+9.9%$13.8B+6.7%$12.9B-23.0%$16.8B-8.6%$18.4B+5.5%$17.4B+14.0%$15.3B+5.1%$14.5B-10.6%$16.2B-8.4%$17.7B-28.1%$24.7B+1.1%$24.4B+0.8%$24.2B
Cost of RevenueN/A$8.5B-1.3%$8.6B+11.2%$7.7B+3.2%$7.5B+4.1%$7.2B-26.3%$9.8B-7.4%$10.6B+5.8%$10.0B+12.9%$8.8B+6.9%$8.3B-10.6%$9.2B-7.3%$10.0B-32.2%$14.7B+0.5%$14.6B-0.1%$14.7B
Gross Profit$9.9B$9.5B+7.1%$8.9B+19.6%$7.4B+17.8%$6.3B-16.6%$7.6B+7.9%$7.0B-10.3%$7.8B+5.2%$7.4B+16.1%$6.4B+2.3%$6.3B-10.6%$7.0B-31.0%$10.2B+2.1%$10.0B+1.9%$9.8B+2.2%$9.6B
R&D ExpensesN/A$771.0M-1.3%$781.0M+49.3%$523.0M+35.8%$385.0M+11.0%$347.0M-21.0%$439.0M-3.3%$454.0M+4.1%$436.0M+28.2%$340.0M+6.3%$320.0M-4.8%$336.0M-5.6%$356.0M-38.2%$576.0M+5.3%$547.0M-1.4%$555.0M
SG&A ExpensesN/A$5.1B-0.8%$5.1B+22.8%$4.2B+15.8%$3.6B+3.4%$3.5B-12.3%$4.0B-10.6%$4.5B+4.4%$4.3B+18.4%$3.6B+4.1%$3.5B-7.3%$3.7B-10.3%$4.2B-26.3%$5.6B+3.9%$5.4B+2.0%$5.3B
Interest ExpenseN/AN/AN/AN/AN/A$147.0MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income TaxN/A$696.0M+67.7%$415.0M-35.4%$642.0M+16.9%$549.0M+58.7%$346.0M+0.3%$345.0M-35.0%$531.0M+19.9%$443.0M-32.9%$660.0M-5.3%$697.0M-45.0%$1.3B+32.9%$953.0M-15.7%$1.1B+3.6%$1.1B-3.2%$1.1B
Net Income$2.6B$2.3B+16.5%$2.0B-85.1%$13.2B+309.1%$3.2B+40.3%$2.3B+17.2%$2.0B-14.8%$2.3B+4.7%$2.2B+45.1%$1.5B-7.2%$1.6B-39.7%$2.7B+26.2%$2.1B+7.1%$2.0B+1.8%$2.0B-20.6%$2.5B

Not reported in any period shown, so not listed: Operating Income, EPS (Diluted).

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

EMR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EMR annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$42.0B-5.2%$44.2B+3.5%$42.7B+17.9%$36.2B+46.6%$24.7B+8.0%$22.9B+11.6%$20.5B+0.5%$20.4B+4.1%$19.6B-9.9%$21.7B-1.6%$22.1B-8.6%$24.2B-2.2%$24.7B+3.7%$23.8B-0.2%$23.9B
Current Assets$8.6B-15.8%$10.2B-26.2%$13.8B+53.5%$9.0B+6.7%$8.4B-4.2%$8.8B+23.4%$7.1B+7.9%$6.6B-19.8%$8.3B-17.1%$10.0B-0.9%$10.0B-7.5%$10.9B-1.2%$11.0B+8.6%$10.1B+8.4%$9.3B
Cash & Equivalents$1.5B-57.0%$3.6B-55.4%$8.1B+254.5%$2.3B-3.5%$2.4B-29.0%$3.3B+121.9%$1.5B+36.7%$1.1B-64.3%$3.1B-3.8%$3.2B+4.2%$3.1B-3.0%$3.1B-3.8%$3.3B+38.4%$2.4B+15.4%$2.1B
Inventory$2.2B+1.5%$2.2B+8.7%$2.0B+0.4%$2.0B-2.5%$2.0B+6.3%$1.9B+2.6%$1.9B+3.7%$1.8B+6.9%$1.7B+40.4%$1.2B-4.5%$1.3B-38.5%$2.1B+8.5%$1.9B-10.8%$2.1B+1.2%$2.1B
Accounts Receivable$3.1B+5.9%$2.9B+16.2%$2.5B+12.9%$2.2B-24.9%$3.0B+6.0%$2.8B-6.1%$3.0B-1.3%$3.0B-1.6%$3.1B+13.7%$2.7B-5.9%$2.9B-42.8%$5.0B+4.4%$4.8B-3.5%$5.0B+10.7%$4.5B
Goodwill$18.2B+0.7%$18.1B+24.8%$14.5B+2.8%$14.1B+102.2%$7.0B+3.5%$6.7B+3.0%$6.5B+1.3%$6.5B+21.4%$5.3B+36.0%$3.9B+1.6%$3.8B-9.2%$4.2B-43.6%$7.5B-6.4%$8.0B-8.5%$8.8B
Total Liabilities$21.7B-4.1%$22.6B+2.5%$22.1B-13.5%$25.5B+72.0%$14.8B+2.5%$14.5B+18.0%$12.3B+7.2%$11.4B+5.3%$10.9B-23.2%$14.2B+1.1%$14.0B-0.4%$14.1B-0.5%$14.1B+4.5%$13.5B+0.5%$13.5B
Current Liabilities$9.8B+70.6%$5.7B+14.1%$5.0B-38.3%$8.2B+30.6%$6.2B+8.0%$5.8B-3.2%$6.0B-3.0%$6.2B+22.2%$5.0B-37.0%$8.0B+2.7%$7.8B-7.7%$8.5B+10.9%$7.6B+6.9%$7.1B+10.3%$6.5B
Long-Term Debt$8.3B+16.3%$7.2B-6.0%$7.6B-6.7%$8.2B+40.8%$5.8B-8.4%$6.3B+47.9%$4.3B+36.3%$3.1B-17.3%$3.8B-6.3%$4.1B-5.5%$4.3B+20.5%$3.6B-12.2%$4.1B+7.1%$3.8B-12.4%$4.3B
Total Equity$20.3B-6.3%$21.6B+4.6%$20.7B+92.9%$10.7B+8.5%$9.9B+17.6%$8.4B+2.1%$8.2B-8.0%$8.9B+2.6%$8.7B+15.2%$7.6B-6.3%$8.1B-20.1%$10.1B-4.4%$10.6B+2.8%$10.3B-1.0%$10.4B
Retained Earnings$40.6B-0.6%$40.8B+1.9%$40.1B+33.2%$30.1B+15.5%$26.0B+4.4%$25.0B+3.1%$24.2B+4.9%$23.1B+4.9%$22.0B+1.3%$21.7B+1.9%$21.3B+7.3%$19.9B+4.9%$18.9B+4.5%$18.1B+4.6%$17.3B

EMR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EMR annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$3.9B$3.1B-7.0%$3.3B+423.1%$637.0M-78.2%$2.9B-18.3%$3.6B+16.0%$3.1B+2.6%$3.0B+3.9%$2.9B+51.3%$1.9B-33.6%$2.9B+13.9%$2.5B-31.5%$3.7B+1.2%$3.6B+19.5%$3.1B-5.6%$3.2B
Capital Expenditures$452.0M$431.0M+2.9%$419.0M+15.4%$363.0M+21.4%$299.0M-26.0%$404.0M-24.9%$538.0M-9.4%$594.0M-3.7%$617.0M+29.6%$476.0M+6.5%$447.0M-24.0%$588.0M-9.7%$651.0M-4.0%$678.0M+2.0%$665.0M+2.8%$647.0M
Free Cash Flow$3.5B$2.7B-8.4%$2.9B+963.1%$274.0M-89.6%$2.6B-17.3%$3.2B+24.6%$2.5B+5.5%$2.4B+6.0%$2.3B+58.4%$1.4B-41.0%$2.4B+25.4%$1.9B-36.2%$3.0B+2.4%$3.0B+24.4%$2.4B-7.7%$2.6B
Investing Cash Flow-$522.0M-$593.0M+88.9%-$5.4B-143.2%$12.4B+332.8%-$5.3B-151.6%-$2.1B-186.5%-$740.0M+37.0%-$1.2B+56.8%-$2.7B-279.7%$1.5B+341.9%-$626.0M-205.9%$591.0M+151.0%-$1.2B-46.9%-$789.0M+2.1%-$806.0M+5.0%-$848.0M
Financing Cash Flow-$3.4B-$4.5B-83.7%-$2.5B+64.0%-$6.8B-433.2%$2.0B+184.6%-$2.4B-375.8%-$509.0M+63.4%-$1.4B+33.5%-$2.1B+41.7%-$3.6B-75.6%-$2.0B+30.6%-$2.9B-15.2%-$2.6B-32.4%-$1.9B-1.8%-$1.9B-0.6%-$1.9B
Dividends Paid$1.2B$1.2B-0.7%$1.2B+0.3%$1.2B-2.0%$1.2B+1.1%$1.2B+0.1%$1.2B0.0%$1.2B-1.6%$1.2B-0.8%$1.2B+1.0%$1.2B-3.3%$1.3B+4.9%$1.2B+2.5%$1.2B+0.9%$1.2B+12.7%$1.0B
Share Buybacks$918.0M$1.2B+168.3%$435.0M-78.3%$2.0B+300.0%$500.0M0.0%$500.0M-46.9%$942.0M-24.6%$1.3B+25.0%$1.0B+150.0%$400.0M-33.4%$601.0M-76.0%$2.5B+138.6%$1.0B-5.6%$1.1B+39.3%$797.0M-14.8%$935.0M

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

EMR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

EMR annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin52.8%+2.0pp50.8%+1.8pp49.0%+3.3pp45.7%-12.8pp58.5%+16.7pp41.8%-0.8pp42.5%-0.2pp42.7%+0.7pp41.9%-1.2pp43.1%0.0pp43.1%-14.1pp57.3%+16.9pp40.3%+0.3pp40.0%+0.6pp39.5%
Net Margin12.7%+1.5pp11.3%-75.9pp87.2%+63.8pp23.4%+5.6pp17.8%+6.1pp11.7%-0.8pp12.6%-0.1pp12.7%+2.7pp9.9%-1.3pp11.3%-5.4pp16.7%+4.6pp12.1%+4.0pp8.1%+0.1pp8.1%-2.2pp10.2%
Return on Equity11.3%+2.2pp9.1%-54.8pp63.9%+33.8pp30.1%+6.8pp23.3%-0.1pp23.4%-4.6pp28.0%+3.4pp24.6%+7.2pp17.4%-4.2pp21.6%-11.9pp33.5%+12.3pp21.2%+2.3pp18.9%-0.2pp19.1%-4.7pp23.8%
Return on Assets5.5%+1.0pp4.5%-26.5pp30.9%+22.0pp8.9%-0.4pp9.3%+0.7pp8.6%-2.7pp11.3%+0.5pp10.8%+3.0pp7.8%+0.2pp7.5%-4.8pp12.3%+3.4pp8.9%+0.8pp8.1%-0.2pp8.3%-2.1pp10.4%
Current Ratio0.88-0.9x1.77-1.0x2.75+1.6x1.10-0.2x1.35-0.2x1.52+0.3x1.19+0.1x1.07-0.6x1.64+0.4x1.240.0x1.290.0x1.29-0.2x1.440.0x1.420.0x1.45
Debt-to-Equity0.41+0.1x0.330.0x0.37-0.4x0.76+0.2x0.59-0.2x0.75+0.2x0.52+0.2x0.35-0.1x0.44-0.1x0.540.0x0.53+0.2x0.350.0x0.380.0x0.370.0x0.42
FCF Margin14.8%-1.9pp16.7%+14.8pp1.8%-17.2pp19.0%-5.5pp24.5%+9.4pp15.2%+2.0pp13.1%+0.1pp13.1%+3.7pp9.4%-7.3pp16.8%+4.8pp11.9%-5.2pp17.2%+5.1pp12.0%+2.3pp9.8%-0.9pp10.7%

Not reported in any period shown, so not listed: Operating Margin.

Note: The current ratio is below 1.0 (0.88), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

What is Emerson Elec Co's annual revenue?

Emerson Elec Co (EMR) reported $18.0B in total revenue for fiscal year 2025. This represents a 3.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Emerson Elec Co's revenue growing?

Emerson Elec Co (EMR) revenue grew by 3.0% year-over-year, from $17.5B to $18.0B in fiscal year 2025.

Is Emerson Elec Co profitable?

Yes, Emerson Elec Co (EMR) reported a net income of $2.3B in fiscal year 2025, with a net profit margin of 12.7%.

As of fiscal year 2025, Emerson Elec Co (EMR) had $1.5B in cash and equivalents against $8.3B in long-term debt.

Emerson Elec Co (EMR) had a gross margin of 52.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Emerson Elec Co (EMR) had a net profit margin of 12.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Emerson Elec Co (EMR) has a return on equity of 11.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Emerson Elec Co (EMR) generated $2.7B in free cash flow during fiscal year 2025. This represents a -8.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Emerson Elec Co (EMR) generated $3.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Emerson Elec Co (EMR) had $42.0B in total assets as of fiscal year 2025, including both current and long-term assets.

Emerson Elec Co (EMR) invested $431.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Emerson Elec Co (EMR) invested $771.0M in research and development during fiscal year 2025.

Yes, Emerson Elec Co (EMR) spent $1.2B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Emerson Elec Co (EMR) had 562M shares outstanding as of fiscal year 2025.

Emerson Elec Co (EMR) had a current ratio of 0.88 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Emerson Elec Co (EMR) had a debt-to-equity ratio of 0.41 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Emerson Elec Co (EMR) had a return on assets of 5.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Emerson Elec Co (EMR) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Emerson Elec Co (EMR) has an earnings quality ratio of 1.35x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Emerson Elec Co (EMR) scores 36 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top